Cargando…

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma

There is accumulating evidence indicating that long non-coding RNA H19 and its mature product miR-675 play essential roles for tumor growth and progression. However, their prognostic value in human head and neck squamous cell carcinoma (HNSCC), particular in laryngeal carcinoma, remains to be elucid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Guo-fang, Zhang, De-jun, Wen, Lian-ji, Xin, Ding, Liu, Yan, Yu, Duo-jiao, Su, Kai, Zhu, Lin, Guo, Ying-yuan, Wang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165684/ https://www.ncbi.nlm.nih.gov/pubmed/27994496 http://dx.doi.org/10.7150/ijms.16571

Ejemplares similares

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma: Erratum
por: Guan, Guo-fang, et al.
Publicado: (2022)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

Overexpression of lncRNA H19 leads to reduced proliferation in TSCC cells through miR-675-5p/GPR55
por: Piao, Zhengguo, et al.
Publicado: (2020)

miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2
por: Zhou, Yan-Wu, et al.
Publicado: (2016)

lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy
por: Li, Xiangquan, et al.
Publicado: (2016)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

LncRNA NLIPMT Inhibits Tumorigenesis in Esophageal Squamous-Cell Carcinomas by Regulating miR-320/Survivin Axis
por: Li, Demao, et al.
Publicado: (2020)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

E7 Peptide Enables BMSC Adhesion and Promotes Chondrogenic Differentiation of BMSCs Via the LncRNA H19/miR675 Axis
por: Shi, Weili, et al.
Publicado: (2023)

LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression
por: Wang, Ru, et al.
Publicado: (2018)

Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions
por: Peperstraete, Evodie, et al.
Publicado: (2020)

A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Guancheng, et al.
Publicado: (2018)

Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates
por: de Lena, Pelayo G., et al.
Publicado: (2017)

The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

LncRNA-ATB Promotes the Tumorigenesis of Ovarian Cancer via Targeting miR-204-3p
por: Yuan, Donglan, et al.
Publicado: (2020)

The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD
por: Harari-Steinfeld, Rona, et al.
Publicado: (2021)

Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p
por: Hu, Weiming, et al.
Publicado: (2021)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma
por: Yang, Cuifang, et al.
Publicado: (2022)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Wu, Congxiao, et al.
Publicado: (2022)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
por: Xiang, Junwei, et al.
Publicado: (2022)

The miR-545/374a Cluster Encoded in the Ftx lncRNA is Overexpressed in HBV-Related Hepatocellular Carcinoma and Promotes Tumorigenesis and Tumor Progression
por: Zhao, Qi, et al.
Publicado: (2014)

lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma
por: Zhang, Shuhua, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma
por: Ji, Yanping, et al.
Publicado: (2020)

Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression
por: Tang, Jianmin, et al.
Publicado: (2022)

LncRNA AL161431.1 predicts prognosis and drug response in head and neck squamous cell carcinoma
por: Zhou, Mingzhu, et al.
Publicado: (2023)

LncRNA H19-Derived miR-675-5p Accelerates the Invasion of Extravillous Trophoblast Cells by Inhibiting GATA2 and Subsequently Activating Matrix Metalloproteinases
por: Ogoyama, Manabu, et al.
Publicado: (2021)

LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis
por: Cui, Dan, et al.
Publicado: (2020)

LncRNA MALAT1/miR‐129 axis promotes glioma tumorigenesis by targeting SOX2
por: Xiong, Zhiyong, et al.
Publicado: (2018)

LncRNA H19-Derived miR-675-3p Promotes Epithelial-Mesenchymal Transition and Stemness in Human Pancreatic Cancer Cells by targeting the STAT3 Pathway
por: Wang, Feng, et al.
Publicado: (2020)

Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway
por: Yang, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b85ukr7ep1d5n4gk2ie4rgvhu6